Medigen Vaccine Biologics (ROCO:6547) Asset Impairment Charge : NT$0.0 Mil (TTM As of Mar. 2025)

View and export this data going back to 2015. Start your Free Trial

What is Medigen Vaccine Biologics Asset Impairment Charge?

Medigen Vaccine Biologics's Asset Impairment Charge for the three months ended in Mar. 2025 was NT$0.0 Mil. Its Asset Impairment Charge for the trailing twelve months (TTM) ended in Mar. 2025 was NT$0.0 Mil.

Medigen Vaccine Biologics Asset Impairment Charge Historical Data

The historical data trend for Medigen Vaccine Biologics's Asset Impairment Charge can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medigen Vaccine Biologics Asset Impairment Charge Chart

Medigen Vaccine Biologics Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Asset Impairment Charge

Get a 7-Day Free Trial

Medigen Vaccine Biologics Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Asset Impairment Charge	Get a 7-Day Free Trial															-	-	-	-	-

Medigen Vaccine Biologics Asset Impairment Charge Calculation

Asset Impairment Charge is the charge against earnings resulting from the aggregate write down of all assets from their carrying value to their fair value.

Asset Impairment Charge for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$0.0 Mil.

Medigen Vaccine Biologics Asset Impairment Charge Related Terms

Thank you for viewing the detailed overview of Medigen Vaccine Biologics's Asset Impairment Charge provided by GuruFocus.com. Please click on the following links to see related term pages.

Medigen Vaccine Biologics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Medigen Vaccine Biologics Corp (ROCO:6547) » Definitions » Asset Impairment Charge

Comparable Companies

Traded in Other Exchanges

N/A

Address

No.68, Shengyi 3rd Road, Hsinchu County, Zhubei, TWN, 30261

Website

https://www.medigenvac.com

Medigen Vaccine Biologics Corp is a biopharmaceutical company focusing on developing and producing vaccines and biologics. It is engaged in developing IP-protected cell-culture technologies for vaccine manufacturing. The company develops vaccines and affordable biosimilars to prevent regional infectious diseases. The group generates revenue from manufacturing and selling a range of COVID-19 vaccines and COVID-19 test kits and provides technical services on cellular therapy product quality and cell culture tests.

Medigen Vaccine Biologics Headlines

No Headlines